Leaflet HEXORALETTEN N 5mg / 1.5mg lozenges


Indicated for: sore throat; oropharyngeal inflammation

Route of administration: oromucosal

Substance: chlorhexidine + benzocaine (antiseptic + local anesthetic)

ATC: R02AA20 (Respiratory system | Throat preparations | Antiseptics)

This combination of chlorhexidine and benzocaine is used to treat pain and inflammation associated with oral cavity infections, such as stomatitis or gingivitis. Chlorhexidine acts as an antiseptic, killing bacteria and preventing infections, while benzocaine is a local anesthetic that relieves pain.

The medication is available in the form of gels, sprays, or mouthwash solutions and should be used as directed by a doctor or pharmacist. It is important not to swallow the product and to avoid contact with the eyes.

Patients should adhere to the treatment duration to prevent bacterial resistance or other complications. It is recommended not to eat or drink immediately after application.

Side effects may include local irritation, a burning sensation, or allergic reactions. In rare cases, severe reactions such as hypersensitivity may occur. Patients should inform their doctor of any unusual symptoms.

General data about HEXORALETTEN N 5mg / 1.5mg

  • Substance: chlorhexidine + benzocaine
  • Date of last drug list: 01-07-2023
  • Commercial code: W64920002
  • Concentration: 5mg / 1.5mg
  • Pharmaceutical form: lozenges
  • Quantity: 16
  • Product type: original
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: JNTL CONSUMER HEALTH (FRANCE) S.A.S. - FRANTA
  • Holder: MCNEIL HEALTHCARE (IRELAND) LIMITED - IRLANDA
  • Number: 6735/2014/01
  • Shelf life: 3 years